肾移植时慢性肾脏病患者的骨密度、微结构和材料强度
研究纳入53例接受肾移植的终末期肾病(ESRD)患者和94例肾功能正常对照,比较骨密度(BMD)、骨小梁评分(TBS)和骨材料强度指数(BMSi)。ESRD患者腰椎、全髋、股骨颈BMD及TBS、BMSi均显著低于对照,尽管甲状旁腺功能控制尚可,提示骨健康受损。
要点
- ESRD患者腰椎BMD 0.966±0.15 vs 对照0.982±0.15(校正p=0.037)。
- ESRD患者全髋BMD 0.852±0.15 vs 对照0.902±0.13(校正p<0.001)。
- ESRD患者TBS 1.20[1.11-1.30] vs 对照1.31[1.19-1.43](校正p<0.001)。
核心结论
- 接受肾移植的ESRD患者骨密度、微结构和力学性能均受损,尽管甲状旁腺功能控制尚可。
- 检测这些异常可能有助于识别移植后骨折高风险患者。
研究设计与样本
- 研究纳入53例接受肾移植的ESRD患者和94例肾功能正常对照。
- 检测实验室指标、腰椎/髋部BMD(DXA)、腰椎TBS和骨材料强度指数(BMSi)。
- 采用多变量线性回归校正年龄、性别和体重指数后比较组间差异。
主要发现
- ESRD患者血清钙9.6±0.7 mg/dl,磷4.4±1.2 mg/dl,全段甲状旁腺激素214 pg/ml [102-390]。
- 14例患者(26.4%)脊柱X线发现无症状陈旧骨折。
- ESRD患者腰椎BMD 0.966±0.15 vs 对照0.982±0.15(校正p=0.037)。
- ESRD患者全髋BMD 0.852±0.15 vs 对照0.902±0.13(校正p<0.001)。
- ESRD患者股骨颈BMD 0.733±0.15 vs 对照0.775±0.12(校正p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Bone health is assessed by bone mineral density (BMD). Other techniques such as trabecular bone score and microindentation could improve the risk of fracture's estimation. Our chronic kidney disease (CKD) patients presented worse bone health (density, microarchitecture, mechanical properties) than controls. More than BMD should be done to evaluate patients at risk of fracture. INTRODUCTION: BMD measured by dual-energy X-ray absorptiometry (DXA) is used to assess bone health in end-stage renal disease (ESRD) patients. Recently, trabecular bone score (TBS) and microindentation that can measure microarchitectural and mechanical properties of bone have demonstrated better correlation with fractures than DXA in different populations. We aimed to characterize bone health (BMD, TBS, and strength) and calcium/phosphate metabolism in a cohort of 53 ESRD patients undergoing kidney transplantation (KT) and 94 controls with normal renal function. METHODS: Laboratory workout, lumbar spine/hip BMD measurements (using DXA), lumbar spine TBS, and bone strength were carried out. The latter was assessed with an impact microindentation device, standardized as percentage of a reference value, and expressed as bone material strength index (BMSi) units. Multivariable linear regression was used to study differences between cases and controls adjusted by age, gender, and body mass index. RESULTS: Among cases, serum calcium was 9.6 ± 0.7 mg/dl, phosphorus 4.4 ± 1.2 mg/dl, and intact parathyroid hormone 214 pg/ml [102-390]. Fourteen patients (26.4%) had prevalent asymptomatic fractures in spinal X-ray. BMD was significantly lower among ESRD patients compared to controls: lumbar 0.966 ± 0.15 vs 0.982 ± 0.15 (adjusted p = 0.037), total hip 0.852 ± 0.15 vs 0.902 ± 0.13 (adjusted p < 0.001), and femoral neck 0.733 ± 0.15 vs 0.775 ± 0.12 (adjusted p < 0.001), as were TBS (1.20 [1.11-1.30] vs 1.31 [1.19-1.43] (adjusted p < 0.001)) and BMSi (79 [71.8-84.2] vs 82. [77.5-88.9] (adjusted p = 0.005)). CONCLUSIONS: ESRD patients undergoing transplant surgery have damaged bone health parameters (density, microarchitecture, and mechanical properties) despite acceptably controlled hyperparathyroidism. Detecting these abnormalities may assist in identifying patients at high risk of post-transplantation fractures.
引用
- Pérez-Sáez MJ, Herrera S, Prieto-Alhambra D, et al. Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation. Osteoporos Int. 2017. PMID: 28497224. doi:10.1007/s00198-017-4065-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。